Report for Kaufman KD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70
Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E
Ref : BMC Endocr Disord , 17 :70 , 2017
Abstract : Lee_2017_BMC.Endocr.Disord_17_70
ESTHER : Lee_2017_BMC.Endocr.Disord_17_70
PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70
PubMedID: 29110647

Title : Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes - Yoon_2011_Int.J.Clin.Pract_65_154
Author(s) : Yoon KH , Shockey GR , Teng R , Golm GT , Thakkar PR , Meehan AG , Williams-Herman DE , Kaufman KD , Amatruda JM , Steinberg H
Ref : Int J Clin Pract , 65 :154 , 2011
Abstract : Yoon_2011_Int.J.Clin.Pract_65_154
ESTHER : Yoon_2011_Int.J.Clin.Pract_65_154
PubMedSearch : Yoon_2011_Int.J.Clin.Pract_65_154
PubMedID: 21235696

Title : Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis - Engel_2010_Int.J.Clin.Pract_64_984
Author(s) : Engel SS , Williams-Herman DE , Golm GT , Clay RJ , Machotka SV , Kaufman KD , Goldstein BJ
Ref : Int J Clin Pract , 64 :984 , 2010
Abstract : Engel_2010_Int.J.Clin.Pract_64_984
ESTHER : Engel_2010_Int.J.Clin.Pract_64_984
PubMedSearch : Engel_2010_Int.J.Clin.Pract_64_984
PubMedID: 20412332

Title : Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes - Williams-Herman_2010_BMC.Endocr.Disord_10_7
Author(s) : Williams-Herman D , Engel SS , Round E , Johnson J , Golm GT , Guo H , Musser BJ , Davies MJ , Kaufman KD , Goldstein BJ
Ref : BMC Endocr Disord , 10 :7 , 2010
Abstract : Williams-Herman_2010_BMC.Endocr.Disord_10_7
ESTHER : Williams-Herman_2010_BMC.Endocr.Disord_10_7
PubMedSearch : Williams-Herman_2010_BMC.Endocr.Disord_10_7
PubMedID: 20412573

Title : Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement - Alba_2009_Curr.Med.Res.Opin_25_2507
Author(s) : Alba M , Sheng D , Guan Y , Williams-Herman D , Larson P , Sachs JR , Thornberry N , Herman G , Kaufman KD , Goldstein BJ
Ref : Curr Med Res Opin , 25 :2507 , 2009
Abstract : Alba_2009_Curr.Med.Res.Opin_25_2507
ESTHER : Alba_2009_Curr.Med.Res.Opin_25_2507
PubMedSearch : Alba_2009_Curr.Med.Res.Opin_25_2507
PubMedID: 19691426

Title : Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis - Williams-Herman_2008_BMC.Endocr.Disord_8_14
Author(s) : Williams-Herman D , Round E , Swern AS , Musser B , Davies MJ , Stein PP , Kaufman KD , Amatruda JM
Ref : BMC Endocr Disord , 8 :14 , 2008
Abstract : Williams-Herman_2008_BMC.Endocr.Disord_8_14
ESTHER : Williams-Herman_2008_BMC.Endocr.Disord_8_14
PubMedSearch : Williams-Herman_2008_BMC.Endocr.Disord_8_14
PubMedID: 18954434